Septic arthritis with Listeria monocytogenes during low-dose methotrexate.
We describe a 22-year-old female with systemic lupus erythematosus and lymphopenia, who developed septic arthritis of the right knee with Listeria monocytogenes type 1/2 A, whilst on low-dose methotrexate (MTX). So far, septic arthritis due to this microorganism has been reported in two other patients treated with low-dose MTX, one having rheumatoid arthritis and the other psoriatic arthritis. No reports exist on patients treated with other cytotoxic antirheumatic therapies.
Jansen
T L
TL
Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
van Heereveld
H A
HA
Laan
R F
RF
Barrera
P
P
van de Putte
L B
LB
D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001170:Arthritis, Infectious / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007717:Knee; D008088:Listeriosis / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy*; D008231:Lymphopenia / Q000150:complications; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D008875:Middle Aged
D018501:Antirheumatic Agents; D008727:Methotrexate